Detailed explanation of the cost of gosatuzumab treatment

Sacituzumab govitecan (Sacituzumab govitecan) is an innovative drug targeting breast cancer and urothelial cancer. It is particularly effective in treating cancer cases that have metastasized or are difficult to remove with surgery. However, the cost of treatment fluctuates due to multiple factors such as individual patient differences, treatment cycles, and drug sources.

The dosage of gosatuzumab is adjusted based on the patient's weight. On the market, the common specifications of this drug are 180mg or 200mg per bottle. Lighter patients may need one bottle of medication for a single treatment, while heavier patients may need more doses. The standard chemotherapy cycle is usually set to 21 days, during which the patient may need to receive several injections depending on the treatment plan.

The price of drugs is not fixed and is affected by multiple factors such as regional differences and supply chain conditions. In the domestic market, the price of each bottle of gosatuzumab is approximately RMB 10,000. However, if you look at international markets, such as Europe, the United States or Singapore, the price may rise to around 30,000 yuan. It is worth noting that although the ingredients of the drugs on these markets are basically the same as those of domestic original drugs, patients who choose imported drugs will also need to bear additional costs of international transportation and possible exchange rate fluctuations.

Based on the above factors, the cost of a course of gosatuzumab treatment will vary from person to person, and the range of variation is large. According to estimates, the total cost of a complete course of treatment may range from tens to hundreds of thousands of RMB. However, this number is not fixed and needs to be calculated based on the specific condition of the patient and the charging standards of the local hospital.